New Millennium Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.27K | Hold |
200
| – | – | ﹤0.01% | 221 |
|
|
2025
Q1 | $7.24K | Hold |
200
| – | – | ﹤0.01% | 233 |
|
|
2024
Q4 | $8.41K | Hold |
200
| – | – | ﹤0.01% | 244 |
|
|
2024
Q3 | $11.1K | Hold |
200
| – | – | 0.01% | 173 |
|
|
2024
Q2 | $8.22K | Buy |
+200
| New | +$8.22K | 0.01% | 199 |
|
|
2024
Q1 | – | Sell |
-200
| Closed | -$9.56K | – | 323 |
|
|
2023
Q4 | $9.56K | Hold |
200
| – | – | 0.01% | 206 |
|
|
2023
Q3 | $7.13K | Hold |
200
| – | – | 0.01% | 190 |
|
|
2023
Q2 | $9.23K | Hold |
200
| – | – | 0.01% | 175 |
|
|
2023
Q1 | $8.02K | Hold |
200
| – | – | 0.01% | 203 |
|
|
2022
Q4 | $9.27K | Hold |
200
| – | – | 0.01% | 200 |
|
|
2022
Q3 | $8K | Buy |
+200
| New | +$8K | 0.01% | 209 |
|